Interactions Between Organic Anions on Multiple Transporters in Caco-2 Cells-Reference-Cited by-同舟云学术

Interactions Between Organic Anions on Multiple Transporters in Caco-2 Cells

Published:2011-09 Issue:9 Volume:100 Page:3817-3830
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Grandvuinet Anne Sophie,Steffansen Bente

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference56 articles.

1. Food and Drug Administration. 2006. Drug interaction studies—Study design, data analysis, and implications for dosing and labeling. Guidance for industry (draft).

2. European Medicines Agency. 2010. Guideline on the investigation of drug interactions (draft).

3. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability;Hidalgo;Gastroenterology,1989

4. Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR;Maubon;Fundam Clin Pharmacol,2007

5. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories;Hayeshi;Eur J Pharm Sci,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic in vitro studies indicate that the clinical drug–drug interactions between protease inhibitors and rosuvastatin are driven by inhibition of intestinal BCRP and hepatic OATP1B1 with minimal contribution from OATP1B3, NTCP and OAT3;Pharmacology Research & Perspectives;2023-02-22

2. Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption;Pharmaceutics;2021-06-15

3. Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside;Pharmacology & Therapeutics;2020-07

4. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach;Molecular Pharmaceutics;2019-09-27

5. In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein;European Journal of Pharmaceutical Sciences;2018-05